코엔원

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There aren't enough data on how to get adhd medication without diagnosis exposure to ADHD for a long time could affect the fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the foetus. Physicians don't have the data to provide clear recommendations however they can provide information on risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who took stimulants during the early stages of pregnancy and those who had not. Clinical geneticists, pediatric cardiologists and other experts reviewed the cases in order to make sure that the classification was correct and to eliminate any bias.

The study conducted by the researchers had some limitations. In particular, they were unable to separate the effects of the medication from the underlying disorder. This limitation makes it difficult for researchers to establish whether the small differences observed between the groups that were exposed to medication for adhd and depression use or if they were caused by co-morbidities. Additionally the study did not examine the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers had taken ADHD medication during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had stopped their medications before or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

Researchers suggest that the small risks posed by the use of intuitive adhd medication medication during pregnancies in the early stages may be offset by the greater benefits for baby and mother of continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, if possible, help them develop strategies to improve their coping abilities that may minimize the effects of her disorder on her daily functioning and relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether to keep or end treatment during pregnancy is one that more and more physicians have to face. These decisions are often made without clear and authoritative evidence. Instead, physicians must weigh their own knowledge and experience, as well as the experiences of other physicians and the research on the topic.

Particularly, the issue of possible risks to the infant can be difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and a lot of the results are conflicting. The majority of studies focus on live births, which may underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study discussed in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have found no connection and the majority of studies show a neutral or even slightly negative effect. As a result, a careful risk/benefit analysis must be conducted in every situation.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In a recent article in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. Furthermore, a loss of medication may affect the ability to do jobs and drive safely, which are important aspects of daily life for many people suffering from starting adhd Medication adults.

She suggests that women who are unsure whether to continue taking the medication or stop due to pregnancy, educate their family members, coworkers and their friends about the condition, its impact on daily functioning and the advantages of staying on the current treatment plan. In addition, educating them can help the woman feel supported in her struggle with her decision. Certain medications can be passed through the placenta. If the patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug may be transferred to her baby.

Risk of Birth Defects

As the use and abuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the potential adverse effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. Using two massive data sets researchers were able to look at more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers of the study did not discover any connection between early use of medication and other congenital anomalies, like facial deformities or club feet. The results are in the same vein as previous studies which showed an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication prior to the birth of their child. This risk increased in the later part of pregnancy, when a lot of women begin to discontinue their ADHD medication.

Women who took ADHD medication during the first trimester were more likely to require a caesarean delivery, have a low Apgar after birth and had a baby that required help breathing after birth. However the researchers of the study were not able to eliminate selection bias by restricting the study to women who did not have other medical issues that could have contributed to the findings.

Researchers hope their research will provide doctors with information when they meet pregnant women. They suggest that although the discussion of risks and benefits is important but the decision to stop or keep treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is a possibility to think about, it isn't recommended due to the high prevalence of depression and other mental problems among women who are pregnant or have recently given birth. Furthermore, research suggests that women who decide to stop taking their medications are more likely to have a difficult time adjusting to life without them following the birth of their baby.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women who suffer from ADHD who must work through their symptoms while attending physician appointments, making preparations for the arrival of a child and getting used to new routines at home are often faced with a number of difficulties. As such, many women choose to continue taking their ADHD medication throughout the pregnancy.

The majority of stimulant medicines are absorbed by breast milk in low quantities, so the risk to nursing infant is very low. However, the rate of exposure to medication by the newborn may differ based on dosage, how often it is administered and the time of the day the medication is administered. Additionally, different medications enter the baby’s system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't fully comprehended.

Because of the lack of evidence, some doctors might be tempted to stop taking stimulant medication during the course of pregnancy. This is a difficult choice for the patient, who prescribes adhd medication must balance the benefits of keeping her medication against the possible dangers to the fetus. As long as there is no more information, doctors should ask all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal period.

A increasing number of studies have proven that women can continue to take their ADHD medication while they are pregnant and nursing. In response, a growing number of patients are opting to continue their medication. They have found through consultation with their doctor that the benefits of keeping their current medication outweigh potential risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss the medication they are taking with their physician as well as the pros bipolar and adhd medication cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant women suffering from ADHD recognize their symptoms and the root cause, learn about available treatments and to reinforce existing strategies for managing. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a treatment plan for both the mother as well as the child, and monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.